Posttraumatic stress disorder in pediatric patients with implantable cardioverter-defibrillators and their parents

被引:7
|
作者
Schneider, Lauren M. [1 ]
Wong, Jessie J. [2 ]
Adams, Rebecca [2 ]
Bates, Brady [3 ]
Chen, Spenser [4 ]
Ceresnak, Scott R. [5 ]
Danovsky, Michael [3 ]
Hanisch, Debra [4 ]
Motonaga, Kara S. [5 ]
Restrepo, Miguel [3 ]
Shaw, Richard J. [1 ]
Sears, Samuel F. [6 ]
Trela, Anthony [4 ]
Dubin, Anne M. [5 ]
Hood, Korey K. [2 ]
机构
[1] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA USA
[2] Stanford Univ, Sch Med, Div Pediat Endocrinol, Dept Pediat, Stanford, CA USA
[3] Valley Childrens Healthcare, Madera, CA USA
[4] Lucile Packard Childrens Hosp Stanford, Palo Alto, CA USA
[5] Stanford Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Stanford, CA USA
[6] East Carolina Univ, Dept Psychol & Cardiovasc Sci, Greenville, NC USA
关键词
Pediatric; ICD; Psychological; PTSD; Family; QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; ANXIETY; PTSD; SYMPTOMS; FAMILIES; THERAPY; SHOCK;
D O I
10.1016/j.hrthm.2022.06.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND An implantable cardioverter-defibrillator (ICD) in the pediatric patient (and the precipitating events that led to ICD placement) can be traumatic for patients and their families and may lead to posttraumatic stress disorder (PTSD). OBJECTIVES This study aimed to estimate the prevalence of PTSD in pediatric patients with an ICD and their parents and identify the factors associated with PTSD incidence. METHODS Pediatric participants with an ICD aged 8-21 years and parents of children aged 0-21 years completed surveys that included demographic characteristics and PTSD measures. Pediatric participants completed additional psychosocial measures, such as anxiety and depression self-report questionnaires. RESULTS Fifty youth (30% female) and 43 parents (70% female) completed the measures. Six of 50 youth (12%) met the screening criteria for a likely PTSD diagnosis, while 20 of 43 parents (47%) met the cutoff for PTSD on the screening measure. Children with PTSD were more likely to have had a secondary prevention ICD (83% vs 17%; P = .021), meet the clinical cutoff for depression (67% vs 16%; P = .005), and had higher shock anxiety scores (31.7 vs 17.9; P = .003) than children without PTSD. Female gender (57% vs 23%; P = .043) and patient depression (31% vs 5%; P = .042) were associated with PTSD in parents. CONCLUSION Parents were found to be more likely to meet the criteria for PTSD than youth. In youth, PTSD was associated with medical and psychosocial factors, whereas PTSD in parents was associated with being female and child depression. Clinic-based screenings and management planning of emotional functioning are warranted to address psychological distress in patients and parents.
引用
收藏
页码:1524 / 1529
页数:6
相关论文
共 50 条
  • [1] Posttraumatic stress disorder and mortality in VA patients with implantable cardioverter-defibrillators
    Ofman, Peter
    Hoffmeister, Peter
    Kaloupek, Danny G.
    Gagnon, David R.
    Peralta, Adelqui
    Djousse, Luc
    Gaziano, J. Michael
    Rahilly-Tierney, Catherine R.
    CLINICAL CARDIOLOGY, 2018, 41 (05) : 652 - 659
  • [2] Pacemakers and implantable cardioverter-defibrillators in pediatric patients
    Silka, Michael J.
    Bar-Cohen, Yaniv
    HEART RHYTHM, 2006, 3 (11) : 1360 - 1366
  • [3] Use of implantable cardioverter-defibrillators in pediatric patients
    Shannon, KM
    CURRENT OPINION IN CARDIOLOGY, 2002, 17 (03) : 280 - 282
  • [4] Left Ventricular Ejection Fraction Predicts Severity of Posttraumatic Stress Disorder in Patients With Implantable Cardioverter-Defibrillators
    Sawatari, Hiroyuki
    Ohkusa, Tomoko
    Rahamawati, Anita
    Ishikawa, Katsuhiko
    Tsuchihashi-Makaya, Miyuki
    Ohtsuka, Yuko
    Nakai, Mori
    Miyazono, Mami
    Hashiguchi, Nobuko
    Chishaki, Hiroaki
    Sakurada, Harumizu
    Mukai, Yasushi
    Inoue, Shujiro
    Sunagawa, Kenji
    Chishaki, Akiko
    CLINICAL CARDIOLOGY, 2016, 39 (05) : 263 - 268
  • [5] System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients
    Radbill, Andrew E.
    Triedman, John K.
    Berul, Charles I.
    Fynn-Thompson, Francis
    Atallah, Joseph
    Alexander, Mark E.
    Walsh, Edward P.
    Cecchin, Frank
    HEART RHYTHM, 2010, 7 (02) : 193 - 198
  • [6] Implantable cardioverter-defibrillators
    DiMarco, JP
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (19): : 1836 - 1847
  • [7] IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    KUTALEK, SP
    DREIFUS, LS
    ADVANCES IN INTERNAL MEDICINE, VOLUME 38, 1993, 38 : 421 - 438
  • [8] Implantable Cardioverter-Defibrillators in Patients With COPD
    Naksuk, Niyada
    Kunisaki, Ken M.
    Benditt, David G.
    Tholakanahalli, Venkatakrishna
    Adabag, Selcuk
    CHEST, 2013, 144 (03) : 778 - 783
  • [9] Implantable cardioverter-defibrillators in dialysis patients
    Mills, Mark T.
    BMJ EVIDENCE-BASED MEDICINE, 2020, 25 (05) : 187 - 188
  • [10] Implantable cardioverter-defibrillators
    Pinski, SL
    Fahy, GJ
    AMERICAN JOURNAL OF MEDICINE, 1999, 106 (04): : 446 - 458